Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Blood
2016
Cotargeting BCL-2 and BCL-XL for maximal efficacy in ALL.
Naval Daver et al.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
Not cited yet
Cotargeting BCL-2 and BCL-XL for maximal efficacy in ALL. | OpenQuestion